Physician profile
Blake W Johnson
NPI 1760502991
$1,852.66
in general payments reported to CMS, 2019-2025
10 companies · $722 in 2025
The $722 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.20 · 2020: $27.13 · 2021: $186 · 2022: $142 · 2023: $231 · 2024: $525 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,478.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $874.87 | 2020-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Advance Xp |
| Calyxo, INC. | $464.87 | 2025 | Cvac Aspiration System |
| Myovant Sciences INC. | $168.02 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $112.71 | 2022-2024 | Bridion |
| Astellas Pharma US INC | $64.94 | 2021-2025 | Xtandi |
| Vertex Pharmaceuticals Incorporated | $51.20 | 2025 | |
| Sumitomo Pharma America, INC. | $46.00 | 2023 | Gemtesa |
| Pacira Pharmaceuticals Incorporated | $31.40 | 2022 | |
| Abbvie INC. | $20.20 | 2019 | |
| Coloplast Corp | $18.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.